ReachMD

Episodes 1-15 of 71

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Siba Raychaudhuri, MD

    Peer

  1

  

  RestartResume

  The Role of IL-17 in PsA Pathophysiology and Treatment Plans

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Marina Magrey, MD

    Peer

  0

  

  RestartResume

  Quality of Life in Patients with PsA: Disease Domain Impacts

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Marina Magrey, MD

    Peer

  0

  

  RestartResume

  Comprehending the PsA Agents in Late-Stage Clinical Development
• 0

  

  RestartResume

  Results of an Expert Delphi Consensus Survey on Clinical Scenarios Considered...

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Sergio Schwartzman, MD

    Peer

  2

  

  RestartResume

  Managing Spondyloarthritis: The Role of Primary Care Physicians

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Philip Mease, MD

    Peer

  • 

    

    Allan Gibofsky, MD, JD, MACR, FACP, FCLM

    Peer

  1

  

  RestartResume

  Connecting Science to Psoriatic Arthritis Patient Care

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Louis Kuritzky, MD

    Peer

  • 

    

    Robin Dore, MD

    Peer

  2

  

  RestartResume

  A Step-by-Step Guide to Diagnosing SLE in the Primary Care Setting

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Louis Kuritzky, MD

    Peer

  • 

    

    Robin Dore, MD

    Peer

  5

  

  RestartResume

  Primary Care’s Role in SLE: Treating, Monitoring, & Consulting

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Cate Lockhart, PharmD, PhD

    Peer

  13

  

  RestartResume

  The Winding Road to Biosimilar Adoption in the United States

• • 

    

    Philip Mease, MD

    Peer

  • 

    

    Clive Liu, MD, PLLC, FABD

    Peer

  7

  

  RestartResume

  What the PsA LOOP Study Means for Dermatologists & Rheumatologists

• • 

    

    Philip Mease, MD

    Peer

  • 

    

    Clive Liu, MD, PLLC, FABD

    Peer

  6

  

  RestartResume

  Changing the Approach to PsA: A Dermatologist’s Take on the LOOP Study

• • 

    

    Clive Liu, MD, PLLC, FABD

    Peer

  • 

    

    Philip Mease, MD

    Peer

  5

  

  RestartResume

  The Impact of the LOOP Study on PsA: A Rheumatologist’s Take

• • 

    

    Shira Johnson, MD

    Peer

  • 

    

    Felicia Cosman, MD

    Peer

  9

  

  RestartResume

  A Treatment Strategy for Postmenopausal Women with Osteoporosis at High Risk ...

• • 

    

    Marshall Miller

    Peer

  15

  

  RestartResume

  Typhoid Mary’s Recipe for Disaster

• • 

    

    Madelaine A. Feldman, MD, FACR

    Peer

  3

  

  RestartResume

  Should You Opt out of Medicare in Your Rheumatology Practice?

• 1
• 2
• 3
• 4
• 5
• Next